GSK plc: 13F holdings
CIK 11313992026Q2
| Positions | 13 |
|---|---|
| Reported value | $602.2m |
| Filed | 2026-08-13 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| CRISPR THERAPEUTICS AG | 3,220,627 | $175.7m | 29.2% |
| WAVE LIFE SCIENCES LTD | 18,245,691 | $106.0m | 17.6% |
| VIR VIR BIOTECHNOLOGY INC | 8,550,954 | $87.1m | 14.5% |
| BNTX BIONTECH SE | 889,824 | $82.8m | 13.7% |
| IDYA IDEAYA BIOSCIENCES INC | 1,333,333 | $49.7m | 8.3% |
| CYTK CYTOKINETICS INC | 340,434 | $29.0m | 4.8% |
| LYELL IMMUNOPHARMA INC | 1,512,659 | $21.3m | 3.5% |
| SPERO THERAPEUTICS INC | 9,190,606 | $20.3m | 3.4% |
| NKARTA INC | 3,150,732 | $8.9m | 1.5% |
| FULCRUM THERAPEUTICS INC | 1,785,714 | $6.5m | 1.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1131399")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.